Concepedia

Author

N. O’Gorman

King's College HospitalORCID

Also Known As

J Prior, N. O'Gorman, N. O’Gorman, Neil O'Gorman, Neil O’Gorman, V Rousseau

66

Publications

5.3K

Citations

24

H-Index

49

Concepts

All Affiliations

King's College HospitalUniversity of ExeterHarris Birthright Research Centre for Fetal MedicineChinese University of Hong KongHomerton University Hospital
NO

About

N. O’Gorman is an author at King's College Hospital specializing in medicine, obstetrics, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

1.1K

2

Public Health

8

8

1.1K

3

Epidemiology

2

2

809

4

Cell Biology

1

1

62

5

Family Medicine

1

1

96

N. O’Gorman

×

26

Publications

5.1K

Citations

23

H-Index

YearCitations

Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia

Daniel L. Rolnik, D. Wright, Liona C. Poon,

New England Journal of Medicine

2017

2.1K

Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation

N. O’Gorman, D. Wright, Argyro Syngelaki,

American Journal of Obstetrics and Gynecology

2015

609

ASPRE trial: performance of screening for preterm pre‐eclampsia

Daniel L. Rolnik, D. Wright, Liona C. Poon,

Ultrasound in Obstetrics and Gynecology

2017

437

Screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

Min Yi Tan, Argyro Syngelaki, Liona C. Poon,

Ultrasound in Obstetrics and Gynecology

2018

398

Multicenter screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation: comparison with <scp>NICE</scp> guidelines and <scp>ACOG</scp> recommendations

N. O’Gorman, D. Wright, Liona C. Poon,

Ultrasound in Obstetrics and Gynecology

2017

346

Accuracy of competing‐risks model in screening for pre‐eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation

N. O’Gorman, D. Wright, Liona C. Poon,

Ultrasound in Obstetrics and Gynecology

2017

244

Predictive performance of the competing risk model in screening for preeclampsia

D. Wright, Min Yi Tan, N. O’Gorman,

American Journal of Obstetrics and Gynecology

2018

200

Early vaginal progesterone versus placebo in twin pregnancies for the prevention of spontaneous preterm birth: a randomized, double-blind trial

Anoop Rehal, Z. Benkő, C. de Paco Matallana,

American Journal of Obstetrics and Gynecology

2020

96

Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE)

N. O’Gorman, D. Wright, Daniel L. Rolnik,

BMJ Open

2016

81

Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21

Valérie Malan, L. Bussières, Norbert Winer,

JAMA

2018

70

Page 1